252 replies to this topic

[ImmInst]

Investment Analysts' New Coverage for September, 6th (ARNA, ATW, AVD, CSH ...
Jags Report - Sep 6, 2012

stock ratings Investment Analysts' new coverage for Thursday, September 6th: Credit Suisse began coverage on shares of Arena Pharmaceuticals (NASDAQ: ARNA).

Equity Brief: Upgrades and Downgrades for September 6th: AEP, AKS, ARNA ... - Reuters

View the full article

[ImmInst]

Monday's biggest gaining and declining stocks
MarketWatch - 7 minutes ago

Monday's biggest gaining and declining stocks. NEW YORK (MarketWatch) - Here are some of Monday's biggest gaining and declining stocks: Gainers.

View the full article

[ImmInst]

Pre-market Movers For September 10 (AIG, PXP, RIG, TITN, MLNX, KSW, GERN ...
RTT News - 46 minutes ago

FONT-SIZE. 9/10/2012 8:43 AM ET (RTTNews) - Gainers: KSW Inc. (KSW:Quote) is rising 22 percent to $4.96. The company has agreed to be acquired by Related Companies, a privately-owned real estate firm in the United States, for $5.00 per share in cash.

Stocks to Watch: Titan Machinery, KSW, Michael Kors - Wall Street Journal (blog)
Monday's biggest gaining and declining stocks - MarketWatch

View the full article

[ImmInst]

Stocks to Watch: GERN, HPQ, ANR & More
CNBC.com - 38 minutes ago

[HPQ Loading... () ] rose after the company said it would cut 29,000 jobs, an additional 2,000 than previously announced. Coal stocks including Alpha Natural, Peabody, Cliffs Resources, and Arch Coal were on fire for the second consecutive session ...

View the full article

[ImmInst]

Post-Market News: AAPL, MSFT, ZNGA, SHFL, CASY, FIVE, PPHM, YELP, BLK
ValueWalk - 2 hours ago

update. Market Levels. US: Dow: 13254.30 (-0.39%), S&P 500: 1429.08 (-0.61%), NASDAQ: 3104.02 (-1.03%); Europe: CAC: 3506.05 (-0.37%), DAX: 7213.70 (-0.01%), FTSE: 5793.20 (-0.03%).

View the full article

[ImmInst]

Geron, Titan Join '52-week Low Club'
DailyFinance - 2 hours ago

These are the new members of 24/7 Wall St.'s "52-week Low Club." Shares of Geron Corporation (NASDAQ: GERN) fell 55.86% to close at $1.28 on trading volume of 19.5 million shares.

Nasdaq Stocks Heading Lower Today: GERN, ZLCS, TITN, SPRD, NIHD, MLNX - Active Investor

View the full article

[ImmInst]

Stocks End Lower Amid Stimulus Hopes; Geron (GERN) Plunges
iStockAnalyst - 10 hours ago

(By Balaseshan) U.S. stocks ended on a lower note amid hopes about further stimulus from the Federal Reserve. S&P 500 Index shed 0.60 percent to finish at 1,429.24.

Stocks End at Session Lows - Fyxnews

View the full article

[ImmInst]

Volatile Stocks - Secret to Quick Gains ( GERN, SVNT, GTAT, GMCR )
SBWire (press release) - 3 hours ago

Volatile Stocks - Secret to Quick Gains ( GERN, SVNT, GTAT, GMCR ). HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today.

View the full article

[ImmInst]

Daily Stocks Highlight by Insiderslab: Microsoft, Mellanox, Potash, A123 ...
Sacramento Bee - 2 hours ago

VANCOUVER, British Columbia, Sept. 11, 2012 -- /PRNewswire/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Microsoft (NASDAQ:MSFT), Mellanox (NASDAQ:MLNX), Potash (NYSE:POT), A123 ...

View the full article

[ImmInst]

Geron Corp. HALTS Trial and 4 Hot Stocks Attracting Attention
Wall St. Cheat Sheet - Sep 11, 2012

Geron Corporation (NASDAQ:GERN): On Monday, the company stated that it stopped a mid-stage trial of imetelstat as a breast cancer treatment because women treated with the drug were not doing as well as those who were treated with only a standard ...

View the full article

[ImmInst]

Baidu.com Extends Fall (BIDU, GERN, DOLE, HIMX, APP)
Mesh Press (press release) - 6 hours ago

NEW YORK, September 13, 2012 (MESHPRESS) - Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S.

View the full article

[ImmInst]

Stock Analysts' Ratings Reiterations for September, 20th (ADBE, AET, AMD, AXP ...
Jags Report - 3 hours ago

stock ratings Stock Analysts' ratings reiterations for Thursday, September 20th: Adobe Systems (NASDAQ: ADBE) had its buy rating reaffirmed by analysts at UBS AG.

View the full article

[ImmInst]

Zacks Reaffirms Neutral Rating on Geron (GERN)
Jags Report - 5 hours ago

Geron Co. logo Zacks reissued their neutral rating on shares of Geron (NASDAQ: GERN) in a research report released on Thursday morning.

View the full article

[ImmInst]

Hot Stocks (ALKS, CPRX, GERN, JAZZ, BMRN)
Mesh Press (press release) - 56 minutes ago

NEW YORK, September 24, 2012 (MESHPRESS) - Beststocksdaily.com, an investment community with a special focus on updating investors with recent news on the U.S.

View the full article

[ImmInst]

Geron Given "Neutral" Rating at Zacks (GERN)
Zolmax - 18 minutes ago

Geron Co. logo Zacks reissued their neutral rating on shares of Geron (NASDAQ: GERN) in a report released on Thursday. Zacks currently has a $1.75 target price on the stock.

View the full article

[ImmInst]

5 Biotechnology Stocks to Sell Now
Investorplace.com - Sep 19, 2012

This week, the overall grades of five Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

View the full article

[ImmInst]

BIOTIME, INC. : BioTime Forms BioTime Acquisition Corporation
4-traders - Sep 28, 2012

BioTime, Inc. : BioTime Forms BioTime Acquisition Corporation. 09/28/2012 | 12:45pm US/Eastern. Subsidiary will seek to acquire assets and businesses in the stem cell and regenerative medicine fields.

View the full article

[ImmInst]

Nasdaq Stocks Heading Lower in Midday Trading: CTIC, ZNGA, MRCY, GERN ...
Active Investor - 2 hours ago

Cell Therapeutics, Inc. (NASDAQ:CTIC) is down 23.04% in midday trading at $1.57. CTIC has traded 19.5 million shares so far today, well above its daily average of 1.3 million shares.

View the full article

[ImmInst]

1 Number All Biotech Investors Need to Watch
DailyFinance - 1 hour ago

In the world of biotech investing, stocks can either soar or plummet depending on clinical trial results. This industry is filled with small-cap companies working toward approval from the Food and Drug Administration and spending millions of dollars on ...

View the full article

[ImmInst]

1 Number All Biotech Investors Need to Watch
DailyFinance - Oct 6, 2012

In the world of biotech investing, stocks can either soar or plummet depending on clinical trial results. This industry is filled with small-cap companies working toward approval from the Food and Drug Administration and spending millions of dollars on ...

View the full article

[ImmInst]

Nasdaq Stocks Heading Lower in Midday Trading: CTIC, ZNGA, MRCY, GERN ...
Active Investor - Oct 5, 2012

Nasdaq Stocks Heading Lower in Midday Trading: CTIC, ZNGA, MRCY, GERN, FSLR, AEZS. October 5, 2012 By Martin Stephenson Leave a Comment.

View the full article

[ImmInst]

Stocks In News (DTLK, GERN, AEZS, FSLR, SPRT)
Mesh Press (press release) - 1 hour ago

NEW YORK, OCTOBER 08, 2012 (MESHPRESS) - Cogonews.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S.

View the full article

[ImmInst]

Nobel Winner's Stem Cells to Be Tested in Eye Malady in 2013
Businessweek - 12 hours ago

Nobel Winner's Stem Cells to Be Tested in Eye Disease Next Year. Thomas Perlmann of Karolinska Institute presents Sir John B. Gurdon of Britain and Shinya Yamanaka of Japan as winners of the 2012 Nobel Prize in medicine or physiology.

View the full article

[ImmInst]

GE (NYSE: GE) Works with Biopharma Company
Wealth Daily - 2 hours ago

GE's (NYSE: GE) Healthcare unit announced yesterday that it has expanded an existing license agreement with biopharmaceutical company Geron Corporation (NASDAQ: GERN).

View the full article

[ImmInst]

Top Losers in After-hours Today, Oct-9
TveNews.com - 15 minutes ago

These are the stocks dropping the most in after-hours trading on, Tuesday, October 09, 2012. Be sure to check out our After Hours section of TheStockMarketWatch.

View the full article

[ImmInst]

Top Losers in After-hours Today, Oct-9
TveNews.com - 3 hours ago

These are the stocks dropping the most in after-hours trading on, Tuesday, October 09, 2012. Be sure to check out our After Hours section of TheStockMarketWatch.

View the full article

[ImmInst]

Tesla Motors Turns Lower (TSLA, ITUB, WDC, ASNA, GERN)
Mesh Press (press release) - 9 hours ago

NEW YORK, October 10, 2012 (MESHPRESS) - Stockmarketnation.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S.

View the full article

[ImmInst]

Tesla Motors Turns Lower (TSLA, ITUB, WDC, ASNA, GERN)
Mesh Press (press release) - 13 hours ago

NEW YORK, October 10, 2012 (MESHPRESS) - Stockmarketnation.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S.

View the full article

[ImmInst]

3 Biotechnology Stocks to Sell Now
Investorplace.com - 22 hours ago

This week, the overall grades of three Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

View the full article

[ImmInst]

BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative ...
DailyFinance - Sep 19, 2012

BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012. ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) announced that Chief Executive Officer Michael D. West, Ph.

View the full article